GDB’s oral heparin patent application was published in China.

GDB ispleased to announce that the oral heparin patent application (InternationalApplication Number PCT/CN2021/135770) enter into the publication status inChina. The publication date is September 13, 2024. This is the patentapplication to protect the oral heparin formulation for pipeline SHX-020. Theapplication will enter into the national phase of China, US, EU, and Japan et.al. under the PCT pathway.